Research Output per year
Organization profile
Profile Information
The Pharmaceutical Policy and Practice Research Centre provides a platform to enhance quality and quantity of research outputs in a competitive research environment.
The CPPPR aspires to become a leading pharmacy practice research centre to promote high quality research outputs. Our long-term vision aims for a research focus and alignment of our plans with external policies, challenges, and opportunities.
The Centre is planning a one day pharmacy practice research symposium in the summer of 2019.
Fingerprint Dive into the research topics where Pharmaceutical Policy and Practice Centre is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Costs and Cost Analysis
Medicine & Life Sciences
Pharmacies
Medicine & Life Sciences
Medicine
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Telemedicine
Medicine & Life Sciences
Biosimilar Pharmaceuticals
Medicine & Life Sciences
New Zealand
Medicine & Life Sciences
Drug and Narcotic Control
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Andrew Adams
- Department of Pharmacy - Senior Lecturer
- Pharmaceutical Policy and Practice Centre
- School of Applied Sciences
Person: Academic
Adeola Adebisi
- Department of Pharmacy - Senior Lecturer in Pharmacy
- Pharmaceutical Policy and Practice Centre
- School of Applied Sciences
Person: Academic
Saima Afzal
- Department of Pharmacy - Senior Lecturer in Pharmacy Practice
- Pharmaceutical Policy and Practice Centre
- School of Applied Sciences
Person: Academic, Doctor of Philosophy
Research Output 2017 2019
A systematic review of patient‐reported outcomes associated with the use of direct‐acting oral anticoagulants
Afzal, S., Hasan, S. S. & Babar, Z-U-D., 26 Jun 2019, In : British Journal of Clinical Pharmacology.Research output: Contribution to journal › Review article
Anticoagulants
Warfarin
Quality of Life
Observational Studies
Compliance
Cost analysis of type 2 diabetes mellitus treatment in economically developed countries
Ramzan, S., Timmins, P., Hasan, S. S. & Babar, Z-U-D., 2 Jan 2019, In : Expert Review of Pharmacoeconomics and Outcomes Research. 19, 1, p. 5-14 10 p.Research output: Contribution to journal › Review article
Developed Countries
Type 2 Diabetes Mellitus
Costs and Cost Analysis
Health Expenditures
Hypoglycemic Agents
Cross verification of prescribing trends through loop evaluation of physicians, patients and medical store personnel
Husnain, S. Z., Bukhari, N. I., Hussain, K., Babar, Z-U-D., Hashmi, F. K., Saleem, Z., Salman, M. & Curley, L., 22 May 2019, In : BMC Health Services Research. 19, 1, p. 1-10 10 p., 328.Research output: Contribution to journal › Article
Open Access
Physicians
Pakistan
Pharmacists
Pharmacies
Federal Government